In a study that assessed multiple recombinant raccoonpox vaccine candidates for sylvatic plague, the addition of tPA resulted in a 20-fold increase of target protein produced in vitro when compared to the same vaccine construct without tPA after 48 h of infection [30]. Here, PLAT is linked to infection.